U.S. readies plan to vaccinate kids ages 5-11 against COVID-19
US children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician’s office, local pharmacy, and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for elementary school youngsters in a matter of weeks.
Federal regulators will meet over the next two weeks to weigh the safety and effectiveness of giving low-dose shots to the roughly 28 million children in that age group.
Within hours of the formal approval, which is expected after the Food and Drug Administration signs off and a Centers for Disease Control and Prevention advisory panel meets on November 2-3, millions of doses will begin going out to providers across the country, along with the smaller needles needed for injecting young children. Within days of that, the vaccine will be ready to go into arms on a wide scale.
“We’re completing the operational planning to ensure vaccinations for kids ages 5 to 11 are available, easy and convenient,” White House COVID-19 coordinator Jeff Zients said. “We’re going to be ready, pending the FDA and CDC decision.”